Findlay Park Partners LLP Invests $37.13 Million in The Cooper Companies, Inc. $COO

Key Points

• Findlay Park Partners LLP acquired approximately 440,243 shares of The Cooper Companies, Inc., valued at $37.1 million, during the first quarter, representing about 0.22% ownership of the company.
• The Cooper Companies reported a 6.3% year-over-year revenue increase with a net margin of 10.39% and an earnings per share of $0.96 for the latest quarter, exceeding analyst expectations.
• Analyst ratings for Cooper Companies show a consensus rating of "Moderate Buy" with a target price averaging $96.73, despite some recent downgrades from various firms.

Findlay Park Partners LLP bought a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 440,243 shares of the medical device company's stock, valued at approximately $37,134,000. Findlay Park Partners LLP owned approximately 0.22% of Cooper Companies as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in COO. Zions Bancorporation National Association UT bought a new position in shares of Cooper Companies in the 1st quarter worth approximately $33,000. City Holding Co. bought a new position in Cooper Companies during the 1st quarter valued at approximately $34,000. GKV Capital Management Co. Inc. bought a new position in Cooper Companies during the 1st quarter valued at approximately $40,000. Larson Financial Group LLC increased its position in Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after buying an additional 664 shares in the last quarter. Finally, HM Payson & Co. increased its position in Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after buying an additional 532 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on COO shares. Mizuho reduced their price objective on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. Loop Capital set a $100.00 price objective on Cooper Companies in a research report on Tuesday, June 17th. BNP Paribas Exane raised Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective for the company in a research report on Tuesday, July 22nd. Morgan Stanley set a $76.00 target price on Cooper Companies and gave the company an "equal weight" rating in a research note on Thursday. Finally, BNP Paribas upgraded Cooper Companies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $86.64.

Cooper Companies Stock Up 4.4%

COO traded up $2.81 during trading on Friday, hitting $67.39. 4,071,437 shares of the company's stock traded hands, compared to its average volume of 2,593,748. The stock has a market capitalization of $13.48 billion, a price-to-earnings ratio of 33.20, a PEG ratio of 1.63 and a beta of 1.00. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $112.38. The company has a current ratio of 2.12, a quick ratio of 1.23 and a debt-to-equity ratio of 0.29. The company's 50 day simple moving average is $72.29 and its two-hundred day simple moving average is $77.40.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The company's revenue for the quarter was up 5.7% on a year-over-year basis. During the same period last year, the business posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.